sergolexole has been researched along with lysergic acid in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, ML; Mann, JJ; McBride, PA; Nimchinsky, E | 1 |
| Cohen, ML; Fuller, RW; Parli, CJ | 1 |
| Foreman, MM; Hall, JL; Love, RL | 1 |
| Cohen, ML; Fuller, RW; Kurz, KD; Mason, NR; Meyers, DB; Parli, CJ; Smallwood, JK; Toomey, RE | 1 |
| Cohen, ML; Cushing, DJ | 1 |
| Brooks, SA; Lachno, DR; Obermeyer, BD | 1 |
| Benedict, CR; Pakala, R; Willerson, JT | 1 |
| Benedict, CR; Pakala, R | 1 |
| Benedict, CR; Katagiri, T; Koba, S; Pakala, R; Watanabe, T | 2 |
| Benedict, C; Pakala, R | 1 |
| Benedict, CR; Katagiri, T; Pakala, R; Watanabe, T | 1 |
12 other study(ies) available for sergolexole and lysergic acid
| Article | Year |
|---|---|
Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists-LY53857, sergolexole, and LY237733.
Topics: Adult; Ergolines; Female; Humans; Ketanserin; Lysergic Acid; Male; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Serotonin; Ritanserin; Serotonin; Serotonin Antagonists | 1990 |
5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067).
Topics: Administration, Oral; Animals; Corticosterone; Ergolines; In Vitro Techniques; Lysergic Acid; Male; Rats; Rats, Inbred SHR; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship | 1989 |
The role of the 5-HT2 receptor in the regulation of sexual performance of male rats.
Topics: Amphetamines; Animals; Copulation; Ejaculation; Ergolines; Female; Lysergic Acid; Male; Piperidines; Prazosin; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Sexual Behavior, Animal | 1989 |
Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
Topics: Animals; Brain; Corticosterone; Dose-Response Relationship, Drug; Ergolines; Guinea Pigs; Heart; Lysergic Acid; Male; Membranes; Muscle, Smooth, Vascular; Pergolide; Quipazine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin Antagonists; Trachea | 1988 |
Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
Topics: 5-Methoxytryptamine; Animals; Coronary Vessels; Endothelium, Vascular; Ergolines; In Vitro Techniques; Lysergic Acid; Muscle Contraction; Muscle, Smooth, Vascular; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Swine | 1993 |
Automated high-performance liquid chromatographic method for the analysis of two novel ergoline compounds in human plasma.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Humans; Lysergic Acid; Sensitivity and Specificity; Serotonin Antagonists | 1997 |
Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Cell Division; Cells, Cultured; DNA; Dogs; Drug Synergism; Lysergic Acid; Muscle, Smooth, Vascular; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Thromboxane A2; Thymidine | 1997 |
Effect of serotonin and thromboxane A2 on endothelial cell proliferation: effect of specific receptor antagonists.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cell Division; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Lysergic Acid; Male; Muscle, Smooth, Vascular; Pentanoic Acids; Platelet Aggregation; Pyridines; Rabbits; Serotonin; Serotonin Antagonists; Thromboxane A2; Thromboxane-A Synthase; Thymidine; Vasoconstrictor Agents | 1998 |
Vascular smooth muscle proliferation: synergistic interaction between serotonin and low density lipoproteins.
Topics: Animals; Cell Division; Lipoproteins, LDL; Lysergic Acid; Mitogens; Muscle, Smooth, Vascular; Pertussis Toxin; Rabbits; Serotonin; Serotonin Antagonists; Virulence Factors, Bordetella | 1999 |
Synergy between thrombin and serotonin in inducing vascular smooth muscle cell proliferation.
Topics: Animals; Cell Division; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Lysergic Acid; Muscle, Smooth, Vascular; Peptide Fragments; Serotonin; Serotonin Antagonists; Thrombin; Thymidine | 1999 |
Lipid peroxidation product 4-hydroxy-2-nonenal acts synergistically with serotonin in inducing vascular smooth muscle cell proliferation.
Topics: Acetylcysteine; Aldehydes; Animals; Antioxidants; Aorta, Thoracic; Arteriosclerosis; Ascorbic Acid; Cell Division; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Drug Synergism; Hydroquinones; Indoles; Lipid Peroxidation; Lysergic Acid; Male; Mitogens; Muscle, Smooth, Vascular; Pertussis Toxin; Protein Kinase C; Protein-Tyrosine Kinases; Rabbits; Serotonin; Serotonin Antagonists; Virulence Factors, Bordetella; Vitamin E | 2001 |
Lysophosphatidylcholine and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular smooth muscle cell proliferation.
Topics: Animals; Antioxidants; Cell Count; Cell Division; DNA; Drug Synergism; Humans; Hydrogen Peroxide; In Vitro Techniques; Lipoproteins, LDL; Lysergic Acid; Lysophosphatidylcholines; Male; Muscle, Smooth, Vascular; Rabbits; Reactive Oxygen Species; Serotonin; Serotonin Antagonists | 2001 |